Bgi Shenzhen

Yuanqiang Zou

Liang Xiao

Chuan Liu

Xiaoping Li

Jinghong Yu

Wenbin Xue

Yu Zhang

Qiang Feng

Zhuye Jie

Huijue Jia

Suisha Liang

Huihua Xia

Ying Dai

Mei Lv

Provided is a use ofin the prevention and/or treatment of metabolic diseases.has the function of preventing and/or treating metabolic diseases (such as obesity, diabetes, atherosclerosis-related diseases, cardiovascular disease and hyperuricemia).

Use ofin preventing and/or treating metabolic diseases

The present invention discloses an application ofin preparing a composition for preventing and/or treating lipid metabolism related diseases, for example but not limited to, atherosclerosis related diseases, cardiovascular diseases and obesity.

Application ofin preparing a composition for preventing and/or treating lipid metabolism related diseases

Use ofin the prevention and/or treatment of metabolic diseases such as obesity, diabetes, atherosclerosis-related diseases, and cardiovascular diseases.

Provided is an application ofin the treatment and prevention of obesity-related diseases. Also provided is a composition for the treatment and prevention of obesity and obesity-related diseases.

Intestinal bacteriaand application thereof

Provided are a composition and the uses thereof. Said composition comprisesand/or a metabolite thereof, as well asand/or a metabolite thereof. Said composition can efficiently treat and prevent inflammation, specifically ulcerative colitis, and related diseases thereof by using a combination ofand, and is safe, efficient, exhibits low toxicity and does not easily produce resistance.

Composition and uses thereof

Provided is a use ofin preventing and/or treating inflammation-related diseases. Specifically, in the present disclosure, it was firstly discovered thathas the function of preventing and/or treating inflammation-related diseases (for example, inflammatory bowel disease, such as ulcerative colitis, gastritis, and common enteritis; and rheumatoid arthritis).

Use ofin preventing and/or treating inflammation-related diseases

The present invention discloses an application ofin preparing a preparation for preventing and/or treating lipid metabolism related diseases, such as atherosclerosis related diseases, cardiovascular diseases and obesity.

Application of bacteroides cellulosityticus in preparing a preparation for preventing and/or treating lipid metabolism related diseases

Provided are a biologically purestrain AF52-21 deposited under CGMCC Accession No. 1.5206 and a composition including the same and a carrier. A method for treating an inflammation-related disease in a subject in need thereof is also provided. Theis useful for treating ulcerative colitis and related disorders.

Biologically purestrain, composition including the same and method for treating ulcerative colitis

Provided areand applications thereof. Specifically, thehas the effects for preventing and/or treating inflammation-related diseases, such as inflammatory bowel diseases (such as ulcerative enteritis, gastritis, and general enteritis) and cardiovascular diseases.

and applications thereof

Provided is an application ofin the treatment and prevention of obesity and obesity-related diseases. Also provided is a composition for the treatment and prevention of obesity and obesity-related diseases.

Intestinal bacteria butyribacterintestini and application thereof

Provided areand an application thereof, specifically, use ofin treating and preventing obesity and related diseases thereof. Also provided are a composition for treating and preventing obesity and related diseases thereof, comprising compositions of drugs, drinks, food, or animal feed, and a method for reducing weight and/or blood lipid.

and application thereof

Provided areand an application thereof, specifically, use ofin treating and preventing diabetes and related diseases thereof. Also provided are a composition for treating and preventing diabetes and related diseases thereof, comprising compositions of drugs, drinks, food, or animal feed, and a method for reducing weight, fasting plasma glucose and/or blood lipid, and improving glucose tolerance.

Growing community of inventors

Shenzhen, China

Yuanqiang Zou